Posts Tagged ‘patients’
For patients? Depression, the team of eye care can be better
For depression patients, team care may be better
SEATTLE — Depressed patients who have poorly controlled diabetes or heart disease — or both — often are some of the most unhappy and expensive patients around. But when their depression and physical problems are monitored and treated by a team of primary-care providers, these patients not only feel better, their physical condition improves significantly, researchers from the University of …
Read more on The Wenatchee World
Related Blogs
- Deep Brain Stimulation (DBS) for Depression: Long-Term Followup …
- Diabetes mobile health company snags $48 million from investors …
- Difficult Conversations: Tips for Health Care Providers on …
- Primary Care and Hope Clinic Announces Addition of Chief …
- Depression in Rheumatoid Arthritis Patients Linked to Social …
U.S. M? The m? Family physicians to discuss the possibilities? Miss S IUD patients
U.S. Family Physicians Miss Opportunities to Discuss IUDs with Patients
Intrauterine devices (IUDs) for contraception are safe and effective, but only a small fraction of women in the United States use them. Now, a national survey of family physicians conducted by researchers at Albert Einstein College of Medicine of Yeshiva University, has found that family physicians typically have gaps in knowledge about IUDs, are often uncomfortable discussing them with patients …
Read more on Newswise
Related Blogs
Alemtuzumab Genzyme shows a r? Reduced registration of RecA sustained? Das and disabled people? It is in the five-year review of patients with MS? exit. . .
Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from …
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genzyme today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial.
Read more on Business Wire
Related Blogs
- HOT off the ECTRIMS Press: Genzyme's Campath (alemtuzumab …
- Update on alemtuzumab (Campath) in RRMS | MS News Today
- Castle Megastore's Castle in Wonderland 4th Annual Halloween …
- BUSINESS WIRE: Sopra Group: Good Performance in the Third Quarter …
- Journal of Clinical Oncology publishes IPI-504 Phase 2 study …
Patients experience a quicker recovery of Healing Touch
Patients Experience Faster Recuperation with Healing Touch
Greenwich Hospital is among a growing number of medical facilities utilizing Healing Touch, a gentle, noninvasive therapy shown to facilitate the relaxation response to enhance the healing process.
Read more on Newswise
Related Blogs
- US Tele-Medicine Blog » Blog Archive » Patients Experience Faster …
- » Former Greenwich Hospital employee Telly Colon arrested for …
- Relaxation Practices for Stress Relief | StressRelief-Online.com
- Progressive Muscle Relaxation | Fat Loss Diets
- All About Medical Tourism In India | Weight Loss Diet Information
Show ARIKACE sustained beneficial in the treatment of patients with cystic fibrosis who have Pseudomonas lung infections
ARIKACE Demonstrates Sustained Benefit in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
Transave, Inc., today reported interim results from a multi-cycle Phase II open label clinical trial in cystic fibrosis patients on its lead investigational drug, ARIKACE⢠.  The data indicated that ARIKACE, delivered once daily for 28 consecutive days followed by 56 days off-treatment for four cycles demonstrated statistically significant improvement in lung function that was sustained during …
Read more on PR Newswire via Yahoo! Finance
Related Blogs
- Overcome Infertility-Menstrual Cycle modification-Symptoms, Causes …
- Begin Cystic Mesothelioma | Mesothelioma Lawyers & Attorneys
- USPTO issues article of material letters patent in regard to …
- Yahoo finance gives recommendation on each stock in a 1 to 5 scale …
- Help Fight Cystic Fibrosis: Boomer Esiason Foundation Will Hold …
New data at ASCO Show Gleevec ® Novartis drug Tasigna ® than for patients with newly diagnosed CML
New Data at ASCO Show Novartis Drug Tasigna® Surpasses Gleevec® for Newly Diagnosed CML Patients
Novartis announced today 18-month results showing that Tasigna® capsules significantly surpass the efficacy of Gleevec® tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Read more on PR Newswire via Yahoo! Finance
Related Blogs
New data at ASCO Show Novartis drug Gleevec ® Tasigna ® than for patients with newly diagnosed CML
New Data at ASCO Show Novartis Drug Tasigna® Surpasses Gleevec® for Newly Diagnosed CML Patients
Novartis announced today 18-month results showing that Tasigna® capsules significantly surpass the efficacy of Gleevec® tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Read more on PR Newswire via Yahoo! Finance
Related Blogs
- Epstein–Barr virus involvement in the pathogenesis of hydroa …
- The Science and Technology Blog » Blog Archive » Second-line CML …
- CytRx Initiates Phase 2 Clinical Trial With Bafetinib In B-cell …
- Valuecruncher » Blog Archive » Why hasn't Yahoo Finance changed in …
- Prechter on Yahoo! Finance: "Even $1 Trillion Can't Save the Euro …
In a promising drug for patients with Novartis ASCO deadly diseases such as CML, multiple myeloma. . .
Data At ASCO Show Promise Of Novartis Drugs For Patients With Life-Threatening Diseases Like CML, Multiple Myeloma And …
Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG, announced that nearly 170 abstracts highlighting investigational uses of current therapies and investigational agents in the Novartis Oncology portfolio will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 4 through June 8 in Chicago, IL (1)…
Read more on Medical News Today
Related Blogs
- Cancer Protection is About Making Smart Decisions | vitamin d …
- Lady Gaga may have life-threatening disease | Latest News
- Abbott to present data on 4 investigational oncology compounds at …
- ASCO 2010 Multiple Myeloma Update – Day One – The Myeloma Beacon
- The Science and Technology Blog » Blog Archive » Second-line CML …
Is it illegal to examine the medical records that are not yours or your patients?
I work in a doctor’s office. The office manager looked at the medical records of an employee in the local hospital affiliated with (a program designed to facilitate access to evidence, etc. performed in the hospital and not locally.) Is illegal? I know it is a violation of HIPAA, but what could the phrase (s) is to review the medical records you have no right to consider? I am 100% sure that no information on the release of the files that you would have in their records. I do not want to lose my job or become a target, informing employees. . but I really think this is wrong. Thanks for all that all people!
Clinical trials prove the effectiveness of the treatment of patients with metastases
Clinical Trial Test Helps Measure Effectiveness of Treatment for Patients with Metastatic Cancer
To see if CellSearch could predict patient response to therapy earlier than traditional measures. Patients could be spared the expense and unpleasant side effects of continuing with an ineffective treatment course.
Read more on Newswise

